西酞普兰对慢性心力衰竭伴发抑郁患者近远期预后的影响

Influence of citalopram on short and long-term prognosis in patients with chronic heart failure complicated with depression

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2017, 44(3)
作者
作者单位

西安医学院第二附属医院 ;

摘要
【摘要】探讨西酞普兰对慢性心力衰竭(CHF)合并抑郁患者近、远期疗效的影响。方法 将120例CHF合并抑郁患者根据用药方法分为两组:对照组(n=60)予以常规抗心衰治疗,观察组(n=60)在对照组基础上加用西酞普兰治疗,疗程6个月。比较两组临床疗效、治疗前后心功能、汉密尔顿抑郁量表(HAMD)及明尼苏达心力衰竭生活质量问卷(MLHFQ)评分,随访统计心衰加重再住院率及全因死亡率。结果 观察组的心功能分级疗效总有效率为90.00%,显著高于对照组的78.33%(P<0.05);治疗1、6个月末,观察组的HAMD、MLHFQ评分、左室舒张末期内径(LVEDD)、N末端B型利钠肽原(NT-proBNP)著低于对照组(P<0.05),左心室射血分数(LVEF)、6min步行距离(6WMT)显著高于对照组(P<0.05);随访期间,观察组心衰加重再入院率、全因死亡率分别为38.89%、9.26%,显著低于对照组的76.36%、21.82%(P<0.05)。结论 西酞普兰辅助治疗CHF近期疗效确切,能够改善患者的抑郁症状及生活质量,从而改善心功能及远期预后。
Abstract
【Abstract】 Objective To evaluate the influence of citalopram on short and long-term prognosis in patients with chronic heart failure (CHF) complicated with depression.Methods 120 patients with CHF complicated with depression were divided into two groups according to the therapy method: Patients of control group (n=60) received conventional anti-heart failure treatment,patients of observation group (n=60) received citalopram treatment on the basis of control group for 6 months.The clinical effect, heart function,Hamilton Depression Scale (HAMD) and Minnesota Heart Failure Quality of Life Questionnaire (MLHFQ)score before and after treatment were compared between the two groups,the re-admission and all-cause mortality were counted. Results The total effective rate of cardiac function of observation group was 90.00%, significantly higher than 78.33% of control group (P<0.05); At the end of the one,six months after treatment,the HAMD score,MLHFQ score, Left Ventricular End Diameter Diastolic (LVEDD) and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) of observation group were significantly lower than the control group (P<0.05),while the Left Ventricular Ejection Fraction (LVEF) and 6min Walking Distance (6 WMT) were significantly higher than the control group (P<0.05); At the end of the follow-up period,the re-admission and all-cause mortality were 38.89% and 9.26% of observation group respectively, significantly lower than 76.36%, 21.82% of control group (P<0.05). Conclusion The short-term efficacy of citalopram in the treatment of CHF omplicated with depression is exact,it can improve the patients depressive symptoms and quality of life,so as to improve cardiac function and long - term prognosis.
关键词
【关键词】慢性心力衰竭;西酞普兰;抑郁;临床预后
KeyWord
【Key words】 Chronic heart failure; Citalopram; Depression; Clinical prognosis
基金项目
页码 493-495
  • 参考文献
  • 相关文献
  • 引用本文

丁鹏,张海良,解飞,王西辉*. 西酞普兰对慢性心力衰竭伴发抑郁患者近远期预后的影响 [J]. 国际精神病学杂志. 2017; 44; (3). 493 - 495.

  • 文献评论

相关学者

相关机构